Pfizer to spend $120 mln to boost U.S. COVID pill manufacturing, Health News, ET HealthWorld


Pfizer to spend $120 mln to boost U.S. COVID pill manufacturingPfizer Inc said on Monday it would spend $120 million to expand manufacturing of its COVID-19 antiviral treatment at its Michigan plant, as demand ramps up.

Use of the pill, Paxlovid, authorized to treat newly infected, at-risk people to prevent severe illness, has soared recently as infections rise.

Biden administration officials have pushed for the wider use of Paxlovid, which the government distributes for free.

Follow and connect with us on , Facebook, Linkedin, Youtube





Source link

We will be happy to hear your thoughts

Leave a Reply

Natural Wellness Gifts
Logo
Compare items
  • Total (0)
Compare
0
%d bloggers like this:
Shopping cart